Investing Profile

Roderick Wong

InvestorVC
RTW Investments, Managing Partner
Photo of Roderick Wong, Managing Partner at RTW Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
624 CONNECTIONS
Duke University Network
196 CONNECTIONS
University of Pennsylvania School of Medicine Network
12 CONNECTIONS
cb
RTW Investments Managing Partner
$10.0M - $50.0M
$25.0M
18
CompanyStageDateRound SizeTotal Raised
Lycia Therapeutics
Series DJun 2026$75M
$200M
Co-investors: Clare Ozawa (Versant Ventures), Jeremy Caldwell (Versant Ventures)
CORXEL Pharmaceuticals
Series DJan 2026$290M
Series DJan 2024$160M
Series BJul 2021
$450M
Serapha Bio
Series AJan 2026$140M
$140M
Co-investors: Rajeev Shah (RA Capital)
Yarrow
Series UnknownDec 2025$200M
$200M
Co-investors: Mona Ashiya (OrbiMed Advisors)
Aquestive Therapeutics
Post Ipo EquityAug 2025$85M
$85M
Milestone Pharmaceuticals
Post Ipo DebtMar 2023$130M
Series DOct 2018$80M
$290M
Co-investors: Eric Linsley (BioInnovation Capital), Marco Boorsma (Forbion), Debra K. Liebert (Domain Associates), Ela Borenstein (Kauffman Fellows)
Oricell Therapeutics
Series BFeb 2023$45M
$370M
Co-investors: William Hu (Qiming Venture Partners)
Orchestra BioMed
Series DJan 2022$110M
$110M
Portfolio Manager Davidson Kempner Capital Management2005 - 2009
Analyst Sigma Capital2004 - 2005
Research Associate Cowen and Company2003 - 2003
Duke University BS Economics
Harvard Business School MBA
University of Pennsylvania School of Medicine MD